Animal models | Injection | Dose | Effects | Remarks | References |
---|---|---|---|---|---|
Normal mouse | Intraplantar | 32 nmol/25 μl | ↑Licking, flinching | Disappeared in TRPA1−/− | [223] |
Normal mouse | Intraplantar | 15 nmol/20 μl | ↑Licking, lifting | Disappeared in TRPA1−/− | [224] |
Normal mouse | Intraplantar | 15 nmol/10 μl | ↑Licking, lifting | Disappeared in TRPA1−/− | [225] |
Complete Freund’s adjuvant injected mouse | Intraplantar | 1.5 or 15 mM/10 μl | ↓ Mechanical hypersensitivity | Disappeared in TRPA1−/− | [226] |
Sciatic nerve-injured rat | Intrathecal | 50–200 μg/15 μl | ↓ Mechanical and cold hypersensitivity | Attenuated by PPARγ antagonist | [227] |
Sciatic nerve-injured rat | Intraperitoneal Iintracerebroventricular | 100 μg | ↔ Mechanical and cold hypersensitivity |  | [227] |
Carrageenan-induced inflamed rat | Intraplantar | 30–300 ng/100 μl | ↓ Mechanical hypersensitivity | Attenuated by PPARγ antagonist | [228] |
Formalin-induced TMJ rat | Into temporomandibular joint | 100 ng/50 μl | ↓ Mechanical hypersensitivity | Attenuated by PPARγ antagonist | [228] |
Formalin-induced inflamed rat | Intraplantar | 100 ng/50 μl | ↔ Mechanical and cold hypersensitivity |  | [228] |
PGE2-induced inflamed rat | Intraplantar | 30–300 ng/50 μl | ↓ Mechanical hypersensitivity | Attenuated by PPAR, Opioid receptor, Nitric oxide/cGMP/PKG)/K+ATP pathway antagonists | [228] |
PGE2-induced inflamed rat | Intraganglionic | 100 ng/10 μl | ↔ Mechanical and cold hypersensitivity |  | [228] |
TNFα induced inflamed rat | Intraplantar | 100 ng/100 μl | ↓ Mechanical hypersensitivity |  | [228] |
Formalin-induced TMJ rat | Into temporomandibular joint | 1–100 ng/50 μl | ↓ Mechanical hypersensitivity | Attenuated by PPARγ antagonist, Opioid receptor, (Nitric oxide/cGMP/PKG)/K+ATP pathway antagonists | [229] |